ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

This study is ongoing, but not recruiting participants.
Study NCT00034307.   Last updated on June 23, 2005.   Information provided by ICOS-Texas Biotechnology
Please refer to this study by its ClinicalTrials.gov identifier: NCT00034307


Locations
United States, California
University of California, San Francisco    
      San Francisco, California, United States, 94143
Harbor-UCLA Medical Center    
      Torrance, California, United States, 90502
University of Southern California Hospital, Ambulatory Health Sciences    
      Los Angeles, California, United States, 90033
United States, Colorado
University of Colorado/ Health Science Center    
      Denver, Colorado, United States, 80262
The Children's Hospital    
      Denver, Colorado, United States, 80218
United States, Georgia
Medical College of Georgia    
      Augusta, Georgia, United States, 30912
Emory University Hospital - McKelvey Lung Transplantation Center    
      Atlanta, Georgia, United States, 30322
Dekalb Medical Center    
      Decatur, Georgia, United States, 30033
United States, Illinois
Rush Heart Institute, Center for Pulmonary Heart Disease, Rush-Presbyterian-St. Luke's Medical Center    
      Chicago, Illinois, United States, 60612
United States, Louisiana
LSU - School of Medicine    
      New Orleans, Louisiana, United States, 70112
United States, Maine
Maine Medical Center    
      Portland, Maine, United States, 04102
United States, Maryland
John Hopkins Hospital    
      Baltimore, Maryland, United States, 21287
United States, Massachusetts
Massachusetts General Hospital    
      Boston, Massachusetts, United States, 02114
United States, Michigan
University of Michigan Hospital, Division of Cardiology    
      Ann Arbor, Michigan, United States, 48109
United States, Minnesota
Mayo Clinic - Division of Cardiovascular Disease    
      Rochester, Minnesota, United States, 55905
United States, New York
Columbia Presbyterian Medical Center    
      New York, New York, United States, 10032
United States, North Carolina
Duke University Medical Center    
      Durham, North Carolina, United States, 27710
United States, Ohio
Division of Cardiology - The Ohio State University Medical Center    
      Columbus, Ohio, United States, 43210
The Cleveland Clinic Foundation, Department of Pulmonary and Critical Care    
      Cleveland, Ohio, United States, 44195
United States, Oregon
Oregon Health Sciences    
      Portland, Oregon, United States, 97201
United States, Pennsylvania
University of Pittsburgh Medical Center, CHF/Transplantation Cardiology    
      Pittsburgh, Pennsylvania, United States, 15213
United States, Rhode Island
Pulmonary Division - Rhode Island Hospital    
      Providence, Rhode Island, United States, 02903
United States, Tennessee
Vanderbilt University Medical Center    
      Nashville, Tennessee, United States, 37232
United States, Texas
Baylor College of Medicine Pulmonary & Critical Care Section    
      Houston, Texas, United States, 77030
United States, Wisconsin
University of Wisconsin Medical School    
      Milwaukee, Wisconsin, United States, 53215
Canada, Quebec
SMBD Jewish General Hospital    
      Montreal, Quebec, Canada, H3T 1E2

Sponsors and Collaborators
ICOS-Texas Biotechnology
ICOS Corporation
Texas Biotechnology Corporation

Investigators
Study Director:     Lyn Frumkin, M.D., Ph.D.     ICOS Corporation    





Links to all studies - primarily for crawlers